Donald Robert Schemel is Director & 10% Owner at Panbela Therapeutics, Inc. (PBLA). They have made 1 open-market trade across 1 company since 2016, most recently 2022-10-04.
CIK 0001652854
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases since 2022, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SNBP | SELL | 2016-11-14 | 2016-12-01 | $1.43 | $10K | -18.8% | -3.3% | -3.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.